Trabectedin in the treatment of metastatic soft tissue sarcoma: cost-effectiveness, cost-utility and value of information.
about
Cost-effectiveness of pazopanib in advanced soft tissue sarcoma in the United kingdom.Trabectedin: safety and efficacy in the treatment of advanced sarcomaTreatment of follicular non-Hodgkin's lymphoma with or without rituximab: cost-effectiveness and value of information based on a 5-year follow-up.Quality of Life and Utility in Patients with Metastatic Soft Tissue and Bone Sarcoma: The Sarcoma Treatment and Burden of Illness in North America and Europe (SABINE) Study.Utility values for advanced soft tissue sarcoma health States from the general public in the United kingdomEconomic and Survival Implications of Use of Electric Power Morcellation for Hysterectomy for Presumed Benign Gynecologic Disease.Ridaforolimus: a promising drug in the treatment of soft-tissue sarcoma and other malignancies.Clinical and pharmacokinetic evaluation of trabectedin for the treatment of soft-tissue sarcoma.Cost of treatment in patients with metastatic soft tissue sarcoma who respond favourably to chemotherpy. The SArcoma treatment and Burden of Illness in North America and Europe (SABINE) study.Trabectedin for the treatment of soft tissue sarcomas.Economic Evaluations of Pharmaceuticals Granted a Marketing Authorisation Without the Results of Randomised Trials: A Systematic Review and Taxonomy.Cost-utility analysis of adjuvant therapies for breast cancer in Iran.
P2860
Q33850011-3A02B778-9CFC-4CC7-8087-BECD8B03FA7CQ34628607-5E6A8373-9AA9-4535-B147-11AB9F1D35FFQ34854149-27B20019-2009-483E-BFF6-697F34B3592DQ35897807-1578ABAB-39BE-41E7-96DF-99A641DDEC54Q36731032-6F4FC68E-EE9A-4C25-A2C8-59FD7735D46DQ36848099-B3A144BD-7A22-4E97-95F1-920CA9C191ACQ37898105-1D97F0BB-BA1E-4C86-9721-DFE8F0950E6DQ37969213-CCC2A000-ABF4-4C69-A81D-FF7330CB6760Q38448801-075228FB-91E7-486F-91DD-11814EE8D07AQ38872192-AA9667A6-21EE-4880-A72D-C709DDCBF1F0Q38990039-B6F9A21B-4307-4E7D-B193-06FDAC66291AQ44401570-6EAEEFDB-2488-44C5-871E-8E8E005CD66A
P2860
Trabectedin in the treatment of metastatic soft tissue sarcoma: cost-effectiveness, cost-utility and value of information.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Trabectedin in the treatment o ...... lity and value of information.
@ast
Trabectedin in the treatment o ...... lity and value of information.
@en
Trabectedin in the treatment o ...... lity and value of information.
@nl
type
label
Trabectedin in the treatment o ...... lity and value of information.
@ast
Trabectedin in the treatment o ...... lity and value of information.
@en
Trabectedin in the treatment o ...... lity and value of information.
@nl
prefLabel
Trabectedin in the treatment o ...... lity and value of information.
@ast
Trabectedin in the treatment o ...... lity and value of information.
@en
Trabectedin in the treatment o ...... lity and value of information.
@nl
P2860
P356
P1433
P1476
Trabectedin in the treatment o ...... ility and value of information
@en
P2093
B García San Andrés
P2860
P304
P356
10.1093/ANNONC/MDQ339
P50
P577
2010-07-13T00:00:00Z